No Record Found
Sector
PharmaceuticalsOpen
₹76.93Prev. Close
₹80.97Turnover(Lac.)
₹1.69Day's High
₹76.93Day's Low
₹76.9352 Week's High
₹95.1452 Week's Low
₹10.71Book Value
₹21.77Face Value
₹10Mkt Cap (₹ Cr.)
34.16P/E
47.49EPS
1.62Divi. Yield
017 Sep 2024
12:00 AM
AGM
Announcement Date: 17 Sep, 2024
4 Sep 2025
12:00 AM
Board Meeting
Agenda : Audited Result
5 May 2025
12:00 AM
EGM
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 4.66 | 4.66 | 4.66 | 4.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4.82 | 4.47 | 4.62 | 4.14 |
Net Worth | 9.48 | 9.13 | 9.28 | 8.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 6.59 | 5.08 | 5.09 | 5.08 |
yoy growth (%) | 29.71 | -0.08 | 0.15 | 1.41 |
Raw materials | -3.49 | -2.33 | -2.5 | -2.42 |
As % of sales | 52.96 | 45.99 | 49.22 | 47.63 |
Employee costs | -1.01 | -0.87 | -0.71 | -0.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.54 | 0.37 | 0.34 | 0.34 |
Depreciation | -0.26 | -0.26 | -0.23 | -0.21 |
Tax paid | -0.12 | -0.07 | -0.06 | -0.05 |
Working capital | 0.21 | 0.13 | 0.39 | -0.4 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 29.71 | -0.08 | 0.15 | 1.41 |
Op profit growth | 21 | 12.82 | 4.95 | -9 |
EBIT growth | 32.3 | 13.48 | 2.71 | -7.68 |
Net profit growth | 37.87 | 7.6 | 0.6 | -3.37 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,609.6 | 77.53 | 3,86,196.96 | 753.53 | 0.99 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,013.3 | 68.33 | 1,59,634.22 | 557 | 0.5 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,560.9 | 24.4 | 1,26,082.33 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,580.1 | 60.95 | 1,21,161.41 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,303.4 | 15.78 | 1,08,782.71 | 2,961.2 | 0.61 | 7,788.7 | 345.75 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Tosh Kumar Jain
Whole-time Director
Monika Jain
Whole-time Director
Arihant Kumar Jain
Independent Director
Mohit Kumar
Company Sec. & Compli. Officer
Sohini Bansal
Independent Director
Shruti Gupta
Non Executive Director
Bhumika Parwani
Additional Director
Rajesh Kumar Gupta
Additional Director
MrCheena Golani
Bhagwant Kuti,
Kankhal,
Uttarakhand - 249408
Tel: 91-1334-243833
Website: http://www.deshrakshak.com
Email: deshrakshak@yahoo.com; dral95@yahoo.com; daral96@y
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a proprietoryship Concern by late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Lat...
Read More
Reports by Desh Rakshak Aushdhalaya Ltd
What is the Desh Rakshak Aushdhalaya Ltd share price today?
What is the Market Cap of Desh Rakshak Aushdhalaya Ltd?
What is the PE and PB ratio of Desh Rakshak Aushdhalaya Ltd?
What is the 52 Week High and Low of Desh Rakshak Aushdhalaya Ltd?
What is the CAGR of Desh Rakshak Aushdhalaya Ltd?
What is the shareholding pattern of Desh Rakshak Aushdhalaya Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.